Silo Pharma (SILO) Research & Development (2020 - 2026)
Silo Pharma's Research & Development was $298,418 in Q2 2026, down 58.4% from $717,247 a year earlier and down 70.5% from the prior quarter.
Silo Pharma (SILO) Research & Development (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Silo Pharma's Research & Development was $2.16 million through Jun 30, 2026, down 25.6% year-over-year; for FY2025, it came in at $2.16 million, down 8.8% from FY2024.
- Research & Development shows a five-year compound annual growth rate of 141.6% (FY2020 to FY2025).
- In earlier years, Research & Development was $2.37 million in FY2024 (+180.2%), $845,092 in FY2023 (-34.3%), $1.29 million in FY2022 (+85.4%) and $693,910 in FY2021.
- The Q2 2026 figure marks the lowest quarterly Research & Development since Q3 2023.
- Compared with a year earlier, Research & Development was higher in six of the last eight quarters, with growth averaging 66.3%.
- The best year-over-year quarter for Research & Development over five years was Q3 2022 (growth of 432.9%); the worst was Q4 2025 (a decline of 71.6%).
- Per Business Quant data, SILO's Research & Development in the three quarters before Q2 2026 was $1.01 million (Q1 2026), $306,005 (Q4 2025) and $543,615 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Silo Pharma | 1.82 Mn | 1.82 Mn | - | 298,418.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 298,418.00 |
| Mar 31, 2026 | 1.01 Mn |
| Dec 31, 2025 | 306,005.00 |
| Sep 30, 2025 | 543,615.00 |
| Jun 30, 2025 | 717,247.00 |
| Mar 31, 2025 | 593,962.00 |
| Dec 31, 2024 | 1.08 Mn |
| Sep 30, 2024 | 517,548.00 |
| Jun 30, 2024 | 392,824.00 |
| Mar 31, 2024 | 318,240.00 |
| Dec 31, 2023 | 336,965.00 |
| Sep 30, 2023 | 174,495.00 |
| Jun 30, 2023 | 130,719.00 |
| Mar 31, 2023 | 202,913.00 |
| Dec 31, 2022 | 634,684.00 |
| Sep 30, 2022 | 375,795.00 |
| Jun 30, 2022 | 105,676.00 |
| Mar 31, 2022 | 170,279.00 |
| Dec 31, 2021 | 475,948.00 |
| Sep 30, 2021 | 70,514.00 |
Silo Pharma Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=SILO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "SILO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=SILO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();